CI vs TMO · P/E 2.4, rev $274.90B vs P/E 24, rev $44.56B
Cigna Corp (CI) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
CI currently screens at market cap $71.62B and trailing P/E 2.4. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the CI and TMO stock pages for the full models.
Not investment advice.